Veterinary Excipients Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, Application, Chemical Group, Function), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Excipients Market size was more than USD 1.3 billion in 2026 and is set to grow at a 3.9% CAGR between 2027 and 2036, reaching USD 1.91 billion by 2036. The industry revenue for 2027 is estimated at USD 1.34 billion.
Get more details on this report
Request Free Sample ReportVeterinary Excipients Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to a mature animal health pharmaceutical base, strong formulation capabilities, and consistent demand for excipients improving stability, delivery, and dosing performance.
- Asia Pacific is expanding at 4.9% CAGR, driven by rising veterinary pharmaceutical production, growing companion and livestock care demand, and increasing adoption of advanced formulation systems.
Segment Momentum
- Production Animals held a 59.85% share in 2026 due to large-scale livestock treatment programs that rely on excipients for dosage consistency, formulation stability, and efficient administration across high-volume operations.
- Biologics are growing fastest because they require specialized excipients to preserve activity, enhance stability, and meet the stricter formulation needs of increasingly advanced veterinary therapies.
Market Expansion Drivers
- Rising global pet healthcare expenditure increasing demand for high-quality veterinary pharmaceutical excipients.
- Expanding international regulatory harmonization driving compliance-focused excipient manufacturing investments.
- Growing outsourcing to veterinary CDMOs accelerating specialized excipient production capabilities.
Leading Market Participants
- Major companies in the veterinary excipients market include Croda International Plc (United Kingdom), BASF SE (Germany), Ashland Inc. (USA), JRS Pharma GmbH & Co. KG (Germany), Colorcon Inc. (USA), IOI Oleo GmbH (Germany), Lipoid GmbH (Germany), Gattefossé SAS (France), Azelis Group NV (Belgium), Spectrum Chemical Manufacturing Corp. (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.3 billion
- 2027 Estimated Market Size: USD 1.34 billion.
- Projected Market Size: USD 1.91 billion by 2036
- Growth Forecast: 3.9% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Production Animals (Animal Type) | Pharmaceuticals (Application) | Polymers (Chemical Group) | Solubilizers/ Solvents (Function)
- Emerging Opportunity Segment: Companion Animals (Animal Type) | Biologics (Application) | Lipids (Chemical Group) | Solubilizers/ Solvents (Function)
Market Growth Drivers and Industry Trends
Rising global pet healthcare expenditure increasing demand for high-quality veterinary pharmaceutical excipients
Increasing spending on companion-animal healthcare is supporting greater pharmaceutical treatment activity, which will drive the veterinary excipients market growth. As pet owners and veterinary providers place greater emphasis on preventive care, chronic disease management, and therapeutic treatment, demand is expanding for veterinary medicines formulated with consistent and reliable excipients. These ingredients perform essential functions such as improving drug stability, solubility, palatability, dosage consistency, and shelf life, making high-quality excipients important for the formulation of oral, injectable, and other veterinary dosage forms.
Expanding international regulatory harmonization driving compliance-focused excipient manufacturing investments
Greater alignment of pharmaceutical quality and safety requirements across international markets is encouraging manufacturers to strengthen production and quality-control capabilities, thereby supporting the veterinary excipients market. Harmonized regulatory expectations can require suppliers to demonstrate consistent material quality, traceability, purity, and manufacturing controls across veterinary formulations. This environment encourages investment in compliant production processes, analytical testing, documentation systems, and standardized excipient specifications, particularly among manufacturers seeking to supply veterinary pharmaceutical producers across multiple jurisdictions.
Growing outsourcing to veterinary CDMOs accelerating specialized excipient production capabilities
The increasing use of contract development and manufacturing organizations for veterinary pharmaceutical development is expanding demand for formulation expertise and specialized ingredient capabilities, strengthening the veterinary excipients market. Veterinary CDMOs support drug developers that may lack dedicated manufacturing infrastructure or specialized formulation resources, creating additional requirements for excipients tailored to animal-specific dosage forms and administration needs. Outsourced development can also encourage investment in flexible production capabilities capable of handling different formulations, active ingredients, and veterinary product requirements.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global pet healthcare expenditure increasing demand for high-quality veterinary pharmaceutical excipients | 2.00% | Moderate | North America, Europe | High | Near Term |
| Expanding international regulatory harmonization driving compliance-focused excipient manufacturing investments | 1.60% | High | Europe, North America, Asia Pacific | Medium | Mid Term |
| Growing outsourcing to veterinary CDMOs accelerating specialized excipient production capabilities | 1.30% | Moderate | Asia Pacific, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the veterinary excipients market in 2026, supported by a well-established animal healthcare sector, sophisticated pharmaceutical manufacturing capabilities, and strong demand for formulated veterinary medicines. The region's advanced veterinary care infrastructure and emphasis on product quality encourage consistent use of excipients that improve drug stability, delivery, palatability, and shelf life. Expanding companion animal care and continued development of veterinary therapeutics further sustain demand across pharmaceutical applications.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region as animal healthcare systems develop alongside expanding livestock production and rising companion animal ownership. Increasing attention to animal disease prevention, improving access to veterinary medicines, and growth in domestic pharmaceutical manufacturing are creating broader applications for formulation ingredients. Greater investment in veterinary healthcare infrastructure is also supporting adoption of higher-quality excipients across therapeutic and preventive products.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Quality-Focused IngredientsGermany prioritizes high-performance veterinary excipients that support consistent manufacturing quality and regulatory compliance. Suppliers in Germany concentrate on reliable functional ingredients that enhance product stability while meeting the needs of pharmaceutical manufacturers serving multiple animal health segments.
France 🇫🇷
Livestock Health ApplicationsFrance emphasizes veterinary excipients that support reliable formulations for livestock healthcare and preventive treatment programs. Manufacturers serving France prioritize excipient performance that enhances product stability while addressing practical requirements across commercial animal production systems.
Italy 🇮🇹
Flexible Dosage DevelopmentItaly focuses on veterinary excipients that enable versatile dosage formulations for both companion and farm animals. Pharmaceutical companies in Italy increasingly seek excipient solutions that simplify product development while maintaining formulation quality across diverse veterinary applications.
Japan 🇯🇵
Companion Animal FormulationsJapan focuses on veterinary excipients designed for companion animal pharmaceuticals, where ease of administration and formulation precision remain important. Companies in Japan increasingly refine excipient technologies that improve dosage consistency and support specialized veterinary therapies.
South Korea 🇰🇷
Advanced Manufacturing SupportSouth Korea strengthens its veterinary excipients market through investments in pharmaceutical manufacturing capabilities and modern formulation technologies. Producers in South Korea increasingly develop multifunctional excipients that improve processing efficiency while supporting a broader portfolio of veterinary medicines.
United States 🇺🇸
Formulation InnovationThe U.S. emphasizes advanced veterinary excipients that improve formulation stability, palatability, and controlled drug delivery across companion and livestock animal medicines. Manufacturers increasingly collaborate with animal health companies to develop excipients suited for diverse dosage forms and evolving veterinary treatment requirements.
Segment Leadership and Growth Trends
Veterinary Excipients Market Share (%), by Animal Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Type Segment Analysis: Production Animals (Largest Segment) vs Companion Animals (Fastest-Growing Segment)
Production animals held the largest share of the veterinary excipients market, representing 59.85% in 2026. The segment benefits from the extensive use of veterinary medicines and feed-related formulations in livestock production, where animal health directly influences productivity, disease management, and food supply. Excipients play an important role in improving the stability, palatability, delivery, and overall performance of veterinary formulations, supporting consistent demand across production-animal applications.
Companion animals are experiencing faster growth as pet ownership and expenditure on animal healthcare continue to increase. Pet owners are placing greater emphasis on preventive care, chronic disease management, and convenient medication administration, creating demand for formulations tailored to companion-animal needs. Greater development of palatable and easy-to-administer veterinary medicines is further increasing the relevance of specialized excipients for dogs, cats, and other household pets.
Application Segment Analysis: Pharmaceuticals (Largest Segment) vs Biologics (Fastest-Growing Segment)
The pharmaceuticals segment dominated the veterinary excipients market with a 58.8% share in 2026, reflecting the extensive use of excipients in conventional veterinary drug formulations. These ingredients support essential formulation characteristics such as stability, solubility, palatability, and controlled delivery, making them integral to a wide range of veterinary medicines. Continued demand for effective treatments across livestock and companion-animal healthcare is reinforcing the segment's established position.
Biologics are gaining traction more rapidly as veterinary medicine increasingly incorporates vaccines, therapeutic proteins, and other biologically derived products. These products often require specialized formulation approaches to preserve stability and maintain biological activity, creating opportunities for advanced excipient solutions. Growing emphasis on disease prevention, targeted animal therapies, and sophisticated veterinary treatment options is supporting greater demand for excipients suited to biologic formulations.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Production Animals, Companion Animals | Production Animals | Companion Animals |
| Application | Biologics, Pharmaceuticals, Medicated Feed Additives | Pharmaceuticals | Biologics |
| Chemical Group | Polymers, Alcohols, Lipids, Mineral Salts, Others | Polymers | Lipids |
| Function | Solubilizers/ Solvents, Binders, Stabilizers, Coating, Diluents & Fillers , Others | Solubilizers/ Solvents | Solubilizers/ Solvents |
Competitive Landscape and Market Positioning
Top players in the veterinary excipients market:
1. Croda International Plc (United Kingdom)
2. BASF SE (Germany)
3. Ashland Inc. (USA)
4. JRS Pharma GmbH & Co. KG (Germany)
5. Colorcon Inc. (USA)
6. IOI Oleo GmbH (Germany)
7. Lipoid GmbH (Germany)
8. Gattefossé SAS (France)
9. Azelis Group NV (Belgium)
10. Spectrum Chemical Manufacturing Corp. (USA)
The veterinary excipients market is evolving through increased demand for specialized animal healthcare formulations and improved drug delivery performance. Manufacturers are focusing on advanced excipient technologies that enhance stability, palatability, and bioavailability across veterinary medicines. Expansion into companion animal healthcare and livestock treatment applications is also supporting broader market development.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Croda International Plc (United Kingdom) | |||||||
| BASF SE (Germany) | |||||||
| Ashland Inc. (USA) | |||||||
| JRS Pharma GmbH & Co. KG (Germany) | |||||||
| Colorcon Inc. (USA) | |||||||
| IOI Oleo GmbH (Germany) | |||||||
| Lipoid GmbH (Germany) | |||||||
| Gattefossé SAS (France) | |||||||
| Azelis Group NV (Belgium) | |||||||
| Spectrum Chemical Manufacturing Corp. (USA). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Clariant | Aug-23 | Clariant launched three specialized VitiPure excipients—VitiPure O 80 Superior, VitiPure Meglumine LEX, and VitiPure CO 35—at CPHI Barcelona. These high-purity solubilizers and emulsifiers are engineered for both human and veterinary pharmaceutical applications, supporting the company's strategic focus on supplying advanced ingredients for modern biologics and specialized drug formulations. |
| TheraVet | May-22 | TheraVet entered an exclusive distribution partnership with Nuzoa to launch the BIOCERA-VET product line in Spain. This collaboration leverages Nuzoa’s established veterinary distribution network to accelerate market penetration and commercial accessibility for TheraVet’s specialized veterinary orthopedic solutions. |
| Seppic | Nov-21 | Seppic introduced MONTANIDE GEL P PR, an aqueous adjuvant specifically developed for injectable avian vaccines. This technology-led product innovation expands the company's veterinary portfolio, providing manufacturers with enhanced tools to improve the efficacy and stability of poultry immunization programs. |
| Colorcon | Jul-19 | Colorcon announced plans to construct a new starch manufacturing facility in the Netherlands. This capital expenditure was initiated to scale global production capacity for pharmaceutical excipients, ensuring supply chain resilience and meeting the sustained demand for high-quality functional ingredients across the global pharmaceutical and veterinary sectors. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Excipients Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Dosage Form | Tablets & Capsules, Oral Liquids & Suspensions, Injectables, Topical & Transdermal Forms, Feed Premixes & Powders |
| Distribution Channel | Direct Sales, Veterinary Clinics & Hospitals, Pharmaceutical & Feed Manufacturers, Distributors & Wholesalers, Online Channels |
| Formulation Development Stage | Research & Development Formulations, Clinical & Preclinical Formulations, Commercial Formulations, Reformulated & Generic Products |
Veterinary Excipients Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Animal Health Formulation Trends Assessment |
|
| Veterinary Drug Pipeline Demand Mapping |
|
| Excipient Substitution and Reformulation Outlook |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of veterinary excipients?
How is the veterinary excipients industry expected to grow over the next 10 years?
How is premiumization in companion animal healthcare influencing demand for veterinary excipients?
Why are compliance and regulatory harmonization becoming strategic priorities in the veterinary excipients market?
Why do production animals account for the largest share of the veterinary excipients market?
Why are biologics the fastest-growing application in the veterinary excipients market?
Why does North America lead the veterinary excipients market?
How is Asia Pacific driving growth in veterinary excipients?
Which organizations are considered leaders in the veterinary excipients landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization